A subset of the potentially exhausted CD8+ T cells also showed the expression of Entpd1 (CD39), which was recently identified as a marker to distinguish tumor-specific and bystander CD8+ T cells (Simoni et al., 2018). This evidence concerns the gene CD8A and neoplasm.